|
DE102006042143A1
(de)
*
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
|
DE102006056740A1
(de)
*
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
|
DE102006056739A1
(de)
*
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
|
|
DE102007035367A1
(de)
|
2007-07-27 |
2009-01-29 |
Bayer Healthcare Ag |
Substituierte Aryloxazole und ihre Verwendung
|
|
DE102007036076A1
(de)
|
2007-08-01 |
2009-02-05 |
Bayer Healthcare Aktiengesellschaft |
Dipeptoid-Produgs und ihre Verwendung
|
|
DE102007061763A1
(de)
*
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte azabicyclische Verbindungen und ihre Verwendung
|
|
DE102007061764A1
(de)
*
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Anellierte Cyanopyridine und ihre Verwendung
|
|
US8343966B2
(en)
*
|
2008-01-11 |
2013-01-01 |
Novartis Ag |
Organic compounds
|
|
DE102008013587A1
(de)
*
|
2008-03-11 |
2009-09-17 |
Bayer Schering Pharma Aktiengesellschaft |
Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
|
|
JP2011520997A
(ja)
*
|
2008-05-29 |
2011-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
２−アルコキシ置換ジシアノピリジン類およびそれらの使用
|
|
TW201028381A
(en)
*
|
2008-07-14 |
2010-08-01 |
Shionogi & Co |
Pyridine derivative having ttk inhibition activity
|
|
DE102008062567A1
(de)
|
2008-12-16 |
2010-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Dipeptoid-Prodrugs und ihre Verwendung
|
|
DE102009006602A1
(de)
*
|
2009-01-29 |
2010-08-05 |
Bayer Schering Pharma Aktiengesellschaft |
Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
|
|
EP2440204B1
(en)
|
2009-06-12 |
2013-12-18 |
Bristol-Myers Squibb Company |
Nicotinamide compounds useful as kinase modulators
|
|
CA2811989A1
(en)
*
|
2010-04-23 |
2011-10-27 |
Kineta, Inc. |
Diarylpyridine anti-viral compounds
|
|
JP5911476B2
(ja)
*
|
2010-05-26 |
2016-04-27 |
スノビオン プハルマセウトイカルス インコーポレイテッド |
ヘテロアリール化合物及びその使用方法
|
|
DE102010030688A1
(de)
|
2010-06-30 |
2012-01-05 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte Dicyanopyridine und ihre Verwendung
|
|
US20120058983A1
(en)
|
2010-09-02 |
2012-03-08 |
Bayer Pharma Aktiengesellschaft |
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
|
|
KR20150047609A
(ko)
*
|
2012-08-30 |
2015-05-04 |
니뽄 신야쿠 가부시키가이샤 |
피리딘 유도체 및 의약
|
|
JP6026024B2
(ja)
|
2013-06-27 |
2016-11-16 |
ファイザー・インク |
複素芳香族化合物およびそのドーパミンｄ１リガンドとしての使用
|
|
WO2015150924A2
(en)
*
|
2014-03-14 |
2015-10-08 |
Andes Biotechnologies S.A. |
Pharmaceutical compositions comprising rna and use for treating cancer
|
|
GB201514021D0
(en)
|
2015-08-07 |
2015-09-23 |
Arner Elias Set Jeno |
Novel Pyridines and their use in the treatment of cancer
|
|
ES2846833T3
(es)
|
2016-07-18 |
2021-07-29 |
Janssen Pharmaceutica Nv |
Ligandos de obtención de imágenes de tau por PET
|
|
AU2018218518B2
(en)
|
2017-02-07 |
2022-03-17 |
Oblique Therapeutics Ab |
Sulfinylpyridines and their use in the treatment of cancer
|
|
MX389800B
(es)
|
2017-02-07 |
2025-03-20 |
Oblique Therapeutics Ab |
Piridinas sustituidas con heterociclilsulfonilo y su uso en el tratamiento del cancer
|
|
RU2019128063A
(ru)
|
2017-02-07 |
2021-03-09 |
Облик Терапьютикс Аб |
Углеводородсульфонилзамещенные пиридины и их применение при лечении рака
|
|
BR112019016223A2
(pt)
|
2017-02-07 |
2020-04-07 |
Oblique Therapeutics Ab |
piridinas substituídas por heteroarilsulfonila e uso das mesmas no tratamento de câncer
|